Searched for
GRANULES INDIA NEWS
For investors with long-term perspective: 5 mid-cap stocks from different sectors with upside potential of up to 30%Even before the US-Israel-Iran war began, there was a sort of readjustment taking place in the mid-cap segment – a kind of valuation readju...28 Apr, 2026, 11.46 AM IST- Ahead of Market: 10 things that will decide stock market action on TuesdayThe Nifty 50 and BSE Sensex rebounded on broad-based buying led by pharma, IT, auto and metals. Volatility eased, while analysts signalled ...27 Apr, 2026, 09.31 PM IST
- These large-, mid- and small-cap stocks can give more than 22% return in 1 year, according to analystsWhen a market is in a secular correction due to fears that the economy might take a hit for some reason, the fall is generally across the b...24 Apr, 2026, 06.02 AM IST
- Stocks in news: RIL, TCS, IDFC First Bank, BPCL, SpiceJetIndian equity markets saw profit booking on April 9, ending a five-day rally. Several companies like RIL, TCS, and IDFC First Bank are in f...10 Apr, 2026, 06.01 AM IST
- Stocks in news: LIC, IndiGo, TVS Motor, HCL Tech, GranulesIndiGo's market share rose from 64.4% in December 2024 to 65.2% in January 2025, according to monthly data released by the aviation departm...28 Feb, 2025, 06.11 AM IST
- Buy Granules India, target price Rs 680: Motilal OswalGranules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 13341.19 Crore) operating in Pharmaceut...13 Sep, 2024, 10.09 AM IST
- Big movers on D-Street: What should investors do with Granules India, Nazara Tech and Zomato?The Sensex reached a historic 83,000 level, while the Nifty closed at a lifetime high. Granules India fell 16.47% due to US FDA concerns, N...13 Sep, 2024, 08.28 AM IST
- Buy Granules India, target price Rs 475: Motilal OswalGranules India Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2023.24 Jan, 2024, 09.41 AM IST
- Granules gets USFDA nod to market generic medication to treat high blood pressureThe Hyderabad-based company's product is bioequivalent to the Organon LLC's Cozaar tablets.27 Feb, 2023, 12.11 PM IST
- Buy Granules India, target price Rs 510: Yes SecuritiesGranules India Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2022.28 Oct, 2022, 09.04 AM IST
- Buy Granules India, target price Rs 338: ICICI DirectGranules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 8005.63 Crore) operating in Pharmaceuti...19 Aug, 2022, 10.19 AM IST
- Buy Granules India, target price Rs 345: ICICI DirectGranules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 7309.97 Crore) operating in Pharmaceuti...13 Jul, 2022, 10.55 AM IST
- 2 midcaps and a smallcap that may fly higher in a few weeks"At least for the next six to seven months, midcaps will be in focus and will be giving tremendous returns."23 Jul, 2021, 02.10 PM IST
- Buy Granules India, target price Rs 335: Kotak SecuritiesGranules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 8008.56 Crore) operating in Pharmaceuti...04 Jun, 2021, 09.39 AM IST
- Granules India earmarks capex of Rs 1,000 crore till FY24The Hyderabad-based firm plans to invest in a new manufacturing facility and on expanding production capacities at existing plants.16 May, 2021, 12.52 PM IST
- Granules India says 'voluntarily' recalling ranitidine tabsGranules India has said that it has received multiple queries on the news item for recall of ranitidine by the drug firm. The company is in...13 Jan, 2020, 11.53 AM IST
- Stocks in the news: ZEEL, CDSL, SBI, Granules India, Cipla and DHFLBSE will offload 4 per cent stake in CDSL via an offer for sale (OFS).28 Nov, 2019, 08.46 AM IST
Load More
